DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 09 · Volume 52 · September 2014 DOI: 10.1055/s-004-27678


42. Jahrestagung der Gesellschaft für Gastroenterologie in Bayern e.V.
Augsburg, 23.–24. Oktober 2014

Präsident: Prof. Dr. H. Messmann, Klinikum Augsburg

G1
Posselt, L; Lazic, I; Funk, A; Kirchleitner, S; Schievenbusch, S; Adunka, T; Endres, S; Düwell, P; Rothenfusser, S; Schnurr, M: Targeting RIG-I with 5'ppp-modified RNA for immunotherapy of hepatocellular carcinoma (HCC)
G2
G4
Wohlfahrt, J; Fettelschoss, A; Kündig, T; Hermanns, H; Müllhaupt, B; Schmitt, J; Geier, A: Beneficial Effects on Hepatic Steatosis in a Murine Obesity Model after IL-1 Type Cytokine Inactivation
G6
De Toni, EN; Lu, S; Liebl, J; Rizzani, A; Göke, B; Gallmeier, E; Vollmar, AM; Gerbes, AL: Antiproliferative and proapoptotic effect of the MLK/JNK inhibitor CEP-1347 in hepatocellular carcinoma